Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Brücher BLDM, Stein HJ, Zimmermann F, Werner M, Sarbia M, Busch R, Dittler, HJ, Molls M, Fink U, Siewert JR (2004) Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol 30: 963–971
Siewert JR, Stein HJ, Feith M, Brücher BLDM, Bartels H, Fink U (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234: 360–367
Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT (2005) Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103: 1347–1355
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this paper
Cite this paper
Brücher, B.L.D.M. et al. (2006). Quantifizierung Residualer Tumorzellen beim Oesophaguscarcinom und neoadjuvanter Therapie zur Determinierung der Histopathologischen Response. In: Saeger, H.D., Jauch, K.W., Bauer, H. (eds) Chirurgisches Forum 2006. Deutsche Gesellschaft für Chirurgie, vol 35. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-34668-6_43
Download citation
DOI: https://doi.org/10.1007/3-540-34668-6_43
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-32480-5
Online ISBN: 978-3-540-34668-5
eBook Packages: Medicine (German Language)